SCHEMBL18674229

SCHEMBL18674229

C[C@@H]1[C@@H](N=[N+]=[N-])[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](C)O[C@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18674230 0.87 — —
SCHEMBL18674228 0.85 — —
SCHEMBL18674231 0.81 — —
SCHEMBL17472194 0.75 OGA (0.30) —
SCHEMBL17273886 0.75 OGA (0.30) —
SCHEMBL17265254 0.74 — —
SCHEMBL17274126 0.73 OGA (0.31) —
SCHEMBL16155064 0.71 — —
SCHEMBL16155025 0.71 — —
SCHEMBL17265346 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738677-B2 Amphotericin B derivative with reduced toxicity THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-08-22 — — US disclosed
US-20170088572-A1 AMPHOTERICIN B DERIVATIVE WITH REDUCED TOXICITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-03-30 — — US disclosed
Send feedback